10x Genomics, Inc.
TXG
주식 순위
#2231
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012... Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.
주가
$69.74
마지막 동기화: 2026-10-16
시가총액
$9.09B
변동 (1일)
-3.67%
변동 (1년)
489.48%
국가
US
거래 10x Genomics, Inc. (TXG)
카테고리
Healthcare
10x Genomics, Inc. (TXG)의 EPS
June 2026 기준 EPS TTM: $-0.59
10x Genomics, Inc.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $-0.59입니다. 2024년 말에는 회사의 EPS가 $-1.52였으며, 이는 2023년의 EPS $-2.18와 감소입니다.
10x Genomics, Inc.의 EPS 기록 (2017 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 2026 (TTM) | $-0.59 | 68.57% |
| 2025 | $-0.35 | -76.97% |
| 2024 | $-1.52 | -30.28% |
| 2023 | $-2.18 | 49.32% |
| 2022 | $-1.46 | 175.47% |
| 2021 | $-0.53 | -90.13% |
| 2020 | $-5.37 | 571.25% |
| 2019 | $-0.80 | -90.48% |
| 2018 | $-8.40 | 418.52% |
| 2017 | $-1.62 | 0.00% |
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| $3.48 | -689.83% |
US
|
|
| $1.79 | -403.63% |
AU
|
|
| $1.43 | -342.37% |
US
|
|
| $-1.43 | 142.37% |
US
|
|
| - | - |
US
|
